Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pan-pan Liu

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Cancer Medicine|April 7, 2018
Role of radiation therapy in primary breast diffuse large B-cell lymphoma in the Rituximab era: a SEER database analysisPan-Pan Liu, Ke-Feng Wang, Jie-Tian Jin, et al.
Medical Oncology (Northwood, London, England)|November 8, 2014
A prognostic model based on pretreatment platelet lymphocyte ratio for stage IE/IIE upper aerodigestive tract extranodal NK/T cell lymphoma, nasal typeKe-feng Wang, Bo-yang Chang, Xiao-qin Chen, et al.
Fitoterapia|May 22, 2021
Chemical constituents with inhibition against TNF-α from Merrillanthus hainanensisQian-Cai Jiang, Qi-Qi Wang, Chun-Xia Xiao, et al.
Cancer Research and Treatment|April 12, 2019
Characteristics, Prognostic Factors, and Survival of Patients with NK/T-Cell Lymphoma of Non-upper Aerodigestive Tract: A 17-Year Single-Center ExperienceZe-Long Liu, Xi-Wen Bi, Xue-Wen Zhang, et al.
Frontiers in Oncology|August 28, 2020
Expression of PD-L1 on Monocytes Is a Novel Predictor of Prognosis in Natural Killer/T-Cell LymphomaXue-Wen Zhang, Xi-Wen Bi, Pan-Pan Liu, et al.
Oncotarget|October 30, 2015
Puquitinib mesylate, an inhibitor of phosphatidylinositol 3-kinase p110δ, for treating relapsed or refractory non-Hodgkin's lymphomaHang Yang, Yu Wang, Jing Zhan, et al.
Expert Review of Vaccines|July 21, 2022
Neutralizing antibodies and cellular immune response after two doses of inactivated SARS-CoV-2 vaccine in ChinaLi-Na Yan, Zhong-Xin Zhao, Zhen-Dong Wang, et al.
Journal of Virology|March 23, 2018
Divergent Pathogenic Properties of Circulating Coxsackievirus A6 Associated with Emerging Hand, Foot, and Mouth DiseaseShao-Hua Wang, Ao Wang, Pan-Pan Liu, et al.
Frontiers in Oncology|February 10, 2022
Phase II Study of Gemcitabine, Peg-Asparaginase, Dexamethasone and Methotrexate Regimen for Newly Diagnosed Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Final Analysis With Long-Term Follow-Up and Rational Research for the CombinationYu Wang, Cai-Qin Wang, Peng Sun, et al.
Oncotarget|April 15, 2016
High risk of deep vein thrombosis associated with peripherally inserted central catheters in lymphomaXi Zhang, Jia-Jia Huang, Yi Xia, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Cancer Medicine|April 7, 2018
Role of radiation therapy in primary breast diffuse large B-cell lymphoma in the Rituximab era: a SEER database analysisPan-Pan Liu, Ke-Feng Wang, Jie-Tian Jin, et al.
Medical Oncology (Northwood, London, England)|November 8, 2014
A prognostic model based on pretreatment platelet lymphocyte ratio for stage IE/IIE upper aerodigestive tract extranodal NK/T cell lymphoma, nasal typeKe-feng Wang, Bo-yang Chang, Xiao-qin Chen, et al.
Fitoterapia|May 22, 2021
Chemical constituents with inhibition against TNF-α from Merrillanthus hainanensisQian-Cai Jiang, Qi-Qi Wang, Chun-Xia Xiao, et al.
Cancer Research and Treatment|April 12, 2019
Characteristics, Prognostic Factors, and Survival of Patients with NK/T-Cell Lymphoma of Non-upper Aerodigestive Tract: A 17-Year Single-Center ExperienceZe-Long Liu, Xi-Wen Bi, Xue-Wen Zhang, et al.
Frontiers in Oncology|August 28, 2020
Expression of PD-L1 on Monocytes Is a Novel Predictor of Prognosis in Natural Killer/T-Cell LymphomaXue-Wen Zhang, Xi-Wen Bi, Pan-Pan Liu, et al.
Oncotarget|October 30, 2015
Puquitinib mesylate, an inhibitor of phosphatidylinositol 3-kinase p110δ, for treating relapsed or refractory non-Hodgkin's lymphomaHang Yang, Yu Wang, Jing Zhan, et al.
Expert Review of Vaccines|July 21, 2022
Neutralizing antibodies and cellular immune response after two doses of inactivated SARS-CoV-2 vaccine in ChinaLi-Na Yan, Zhong-Xin Zhao, Zhen-Dong Wang, et al.
Journal of Virology|March 23, 2018
Divergent Pathogenic Properties of Circulating Coxsackievirus A6 Associated with Emerging Hand, Foot, and Mouth DiseaseShao-Hua Wang, Ao Wang, Pan-Pan Liu, et al.
Frontiers in Oncology|February 10, 2022
Phase II Study of Gemcitabine, Peg-Asparaginase, Dexamethasone and Methotrexate Regimen for Newly Diagnosed Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Final Analysis With Long-Term Follow-Up and Rational Research for the CombinationYu Wang, Cai-Qin Wang, Peng Sun, et al.
Oncotarget|April 15, 2016
High risk of deep vein thrombosis associated with peripherally inserted central catheters in lymphomaXi Zhang, Jia-Jia Huang, Yi Xia, et al.
Pageof 8